Improving the Outcome of Patients With Heart Failure: Assessment of Iron Deficiency and Intravenous Iron Replacement

被引:2
|
作者
Yera, Hassan O. [1 ]
Khan, Ahsan [2 ]
Akinlade, Olawale M. [3 ]
Champsi, Asgher [2 ]
Glouzon, Van Nam J. [4 ]
Spencer, Charles [2 ]
机构
[1] Shrewsbury & Telford Hosp NHS Trust, Internal Med, Telford, England
[2] New Cross Hosp, Cardiol Heart & Lung Ctr, Wolverhampton, England
[3] Dumfries & Galloway Royal Infirm, Cardiol, Dumfries, Scotland
[4] New Cross Hosp, Internal Med Heart & Lung Ctr, Wolverhampton, England
关键词
morbidity and mortality; heart failure with reduced ejection fraction; quality improvement; ferric carboxymaltose; iron deficiency anaemia; REDUCED EJECTION FRACTION; FERRIC CARBOXYMALTOSE; EXERCISE CAPACITY; ANEMIA; SUBANALYSIS; PREVALENCE; THERAPY;
D O I
10.7759/cureus.47027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Iron deficiency (ID) has been shown to be a significant co-morbidity in patients with heart failure (HF), independent of their anaemia status. Correction of ID has been shown to improve quality of life, recurrent heart failure hospitalizations and morbidity. A quality improvement project was designed to improve the assessment and treatment of iron deficiency in HF patients in our tertiary care centre.Methods and results An initial baseline dataset was collected, followed by two cycles of interventions to help improve the care of HF patients admitted to our hospital over a two-month period. The Plan-Do-Study-Act (PDSA) cycle approach was applied, with the first intervention involving raising awareness of the importance and need to assess the iron status of HF patients through education provided to doctors, nurses and patients. Furthermore, information leaflets were produced and disseminated across the medical wards and through social media forums. The post-intervention datasets were collected and compared to the baseline outcomes. Baseline data showed that only four (20%) of heart failure patients had their iron status checked. Following the interventions, screening for ID increased to 80% (16), of which 85% (11) of those who identified as iron deficient received intravenous iron replacement.Conclusion The project was successful in improving the practice of screening for iron deficiency and intravenous replacement of iron in patients with HF.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Intravenous ferric carboxymaltose for heart failure with iron deficiency
    Coats, Andrew J. Stewart
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (01) : 134 - 135
  • [22] Iron deficiency in patients with heart failure
    Fitzsimons, Sarah
    Doughty, Robert Neil
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2015, 1 (01) : 58 - 64
  • [23] Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry
    Becher, Peter Moritz
    Schrage, Benedikt
    Benson, Lina
    Fudim, Marat
    Cabrera, Carin Corovic
    Dahlstrom, Ulf
    Rosano, Giuseppe M. C.
    Jankowska, Ewa A.
    Anker, Stefan D.
    Lund, Lars H.
    Savarese, Gianluigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (11) : 1844 - 1854
  • [24] Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
    McDonagh, Theresa
    Macdougall, Iain C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (03) : 248 - 262
  • [25] Intravenous Iron Technique Evaluation in Chronic Heart Failure With Iron Deficiency Anemia
    Gosavi, Rohit
    Jadhav, Nitin B.
    Nashte, Abhijeet
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [26] The effects of intravenous iron therapy in heart failure patients with iron deficiency in Hospital University Sains Malaysia
    Diana, Y. Nur
    Abu Dzarr, A.
    Khairi, O. Mohd
    Haniff, W. I. W. Yus
    Huda, A. Nurul
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 397
  • [27] Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients
    Martin-Malo, Alejandro
    Borchard, Gerrit
    Fluehmann, Beat
    Mori, Claudio
    Silverberg, Donald
    Jankowska, Ewa A.
    ESC HEART FAILURE, 2019, 6 (02): : 241 - 253
  • [28] Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence
    Gonzalez-Costello, Jose
    Cainzos-Achirica, Miguel
    Lupon, Josep
    Farre, Nuria
    Moliner-Borja, Pedro
    Enjuanes, Cristina
    de Antonio, Marta
    Fuentes, Lara
    Diez-Lopez, Carles
    Bayes-Genis, Antoni
    Manito, Nicolas
    Pujol, Ramon
    Comin-Colet, Josep
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 80 : 91 - 98
  • [29] SURVIVAL DIFFERENCES IN HEART FAILURE PATIENTS WITH AND WITHOUT IRON DEFICIENCY/ANEMIA AND BY ORAL AND INTRAVENOUS IRON TREATMENT
    Altevers, J.
    Jacob, C.
    Maas, C.
    Krinke, K.
    Barck, I
    Hardt, T.
    Braun, S.
    VALUE IN HEALTH, 2017, 20 (09) : A606 - A606
  • [30] Effect of Intravenous Iron Therapy in Patients With Heart Failure and Iron Deficiency: A MetaAnalysis of Randomized Controlled Trials
    Jaiswal, Vikash
    Jaiswal, Akash
    Agrawal, Vibhor
    Ang, Song Peng
    Kalra, Kriti
    Bisht, Himanshi
    Tripathi, Apoorva
    Biswas, Monodeep
    CIRCULATION, 2023, 148